Pleno: Mark Gardner

Mark Gardner has joined the board of directors of multiomic instrument platform firm Pleno. He is currently senior VP of molecular genomics and oncology at Quest Diagnostics. Previously, he was senior VP at Corza Health and CEO of OmniSeq. Before that, he held various executive roles at Thermo Fisher Scientific (previously Life Technologies), including VP and general manager of the Ion Torrent business unit.